Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ZYXI - I own a small portion right now, I had sold all of it on the run-up into the $20s, then I repurchased a small bit around $15. If they continue to execute and grow I think they will be in great position but COVID has slowed them down.
69% revenue growth 96% order growth 9/30/2020 ending quarter
77% revenue growth 76% order growth 6/30/2020 ending quarter
66% revenue growth 126% order growth 3/31/2020 ending quarter
Order growth (the leading indicator) took a step back in the 6/30 ending quarter, then started moving again. That caused revenue growth to slow again. With COVID it has been harder for salespeople to get access to doctors in order to sell. However, it has also made it easy to hire people, so they have been hiring salespeople at an accelerated pace. Revenues I think will continue to trend upward caused by all the new salespeople hired and because order growth has already turned back up. However, these salespeople are all dedicated and on a partial salary, so that is depressing the bottom the bottom line. So I think revenues will move up and bottom line will remain depressed for another few quarters, but at some point the bottom line will catch up. In a couple years I think they will have huge profits, but I'm not sure when the bottom line starts to turn up again.
Some people think they are hiring all these people to cover up declining growth or declining demand. They also added a catalog of other generic products to sell, and some people think that was out of desperation. I don't see those things.
They have a blood volume monitor that is ready to go, but they are building a separate sales team for that. My impression is that will take a long time to develop and won't give them profits in the near term, but only drive costs.
Congratulations KiK! I think your repeated wins show you are the best stock picker.
CVLB 9.32 (+23.44%) - another scam having a nice day today. Up from the 5's 4 days ago.
Which drug company stocks to short on this news?
$16.9M of that loss this quarter is in stock options. They haven't had money and have been diluting to fund growth. But their revenue is on a subscription basis. I believe their sales and marketing can go away and they will still have the recurring revenue. They have 2 new telemedicine offerings in the works. They are rapidly introducing new brands. They know how to advertise, they have a telemedicine platform they purchased. The COVID pandemic has increase their business. They are a growth story. I own just a small amount because they aren't profitable, and the lottery ticket, somewhat sketchy feel. But, I think they could stop advertising or reduce it and they would be profitable because of the subscription nature of their revenues. I think investors on the Nasdaq have an appetite for these type of companies. We'll see how it goes.
CVLB Revenue up 252%
They say they expect to be on the Nasdaq in a 1-2 weeks.
https://seekingalpha.com/pr/18087877-conversion-labs-q3-2020-revenue-up-252-to-record-11_0-million
SMDM had a positive conference call.
Here are some notes:
140% of last year sell through - Target?
Struggling to fulfill due to lack of inventory due to demand
Walmart weekend of Thanksgiving, part of November week 1 program. 170% increase from last year
Walmart said they ordered 70,000 pieces less than they should have, demand has continued and said they will not make that mistake next year
Sam's club
continued success
5 products versus last year 3 products
Summer progam sellthrough of 93%
Main item has had a double in sales so far
High-end pedestal has been steady
Costco carries only one product, exceeding number
$199 retail versus $169 last year, no drop in sales
True wifi product
Drop ship numbers up over 300%
Influencers on Tik-Tok promoting items and selling direct through carpool karaoke website
Margins have been great on that
Good inventory position
Sold end-of-life product at full margins
Net of Walmart annual event 32-33% margins
Doing well in Australia, but international is slow
No drop-off in carpool karaoke sales
Should get the ~$400K PPP loan forgiven and reported as income
SMDM .32 in with a .06 quarter. Revs up 15%.
Income up 300%.
Other income of .9M for insurance claim versus 2.4M total income.
https://finance.yahoo.com/news/singing-machine-announces-300-increase-120000473.html
Glad I picked up some on the dip this week.
PGNT net income doubled on a little lower revenue.
LEAT 7.35 (+9%) in with .27 earnings. Revenue up 18%. Net income up 22%.
https://finance.yahoo.com/news/leatt-corp-announces-third-quarter-130000249.html
ORGO Just announced a public offering.
https://finance.yahoo.com/news/organogenesis-holdings-inc-announces-proposed-224000475.html
SMLR (66.40 +6.41 (+10.69%)) Increased revenue 68% yoy. Selling at half the revenue growth rate. 2 new products in the works.
https://finance.yahoo.com/news/semler-reports-record-third-quarter-130300969.html
I prefer more information over less. But their backlog numbers may be conservative anyway.
APT (14.90) reports .58 cents for the quarter
No news on the phase 2 line yet, but still including it in projections. Won't be reporting interquarter backlogs anymore for competitive reasons.
https://www.otcmarkets.com/filing/html?id=14481871&guid=UCdeUpqtI2Ah3th
I lightened my PDEX. I like it long term, but agree this quarter could disappoint. Maybe they have massive interest in their new product with rapid reorders, but that seems unlikely. They have another smaller new product coming in 1q next year.
Wow, they're doing great. I had thought their recent success would be temporary, but these COVID names are sticking around longer than I expected.
APT to $16.30
OBCI +1.84 to $15.44
Looks like a stock market down, COVID stocks up day to me.
On APT, I don't see why margins would get eroded with COVID abating. I don't know, but I doubt that APT has raised the prices on their masks. If anyone has raised their prices it is more likely to be the distributors I would think. Also, although the ordinary masks market is getting saturated, I don't think the N95 mask market is getting saturated, I think there is still a shortage and will be for awhile.
GLGI made .03 number of pallets up but revenue down on "pricing structure"
Does that mean they had lower the pallet prices? Hopefully that is not a trend.
https://www.otcmarkets.com/filing/html?id=14438970&guid=UW-eUK1DvCKAv3h
SMDM Singing Machine is saying they will part of Amazon Prime day. They also have more to recoup from insurance and some Black Friday sales that slid into the coming quarter. On Amazon they have consistent recent reviews. Also, carpool karaoke microphone on Google trends is showing good traffic. Looks like it is shaping up to be a good quarter or two.
https://finance.yahoo.com/news/carpool-karaoke-microphone-featured-amazon-130000669.html
https://trends.google.com/trends/explore?q=Carpool%20karaoke%20microphone&geo=US
https://www.amazon.com/Singing-Machine-Bluetooth-Microphone-CPK545/product-reviews/B07SLFVGSC/ref=cm_cr_arp_mb_viewopt_srt?ie=UTF8&reviewerType=all_reviews&sortBy=recent&pageNumber=1
I own DTEA. I think they'll get a deal on exiting their leases and they have a lot of cash to cover most of the obligation.
APT sells N95 masks which is a much less competitive market.
APT another way to look at it is that news of the expansion could come out any day and drive the price of the stock up. There will definitely be continued high demand for the masks for awhile.
Revenue grew at 87% and will be between 80-120% and maybe more with all the new sales people and as COVID dissipates. With a p/e in the 50s seems like a good risk reward here.
Their quarters will be lumpy, but I would say this is just the beginning of huge quarters.
PDEX ($24.90) up 17% on 59% in revenue because of their new products. $0.64 for the quarter. They are rockin now. The new products are working and they will have a long pipeline with bigger and bigger TAM.
I'm glad to see GLGI margin improvements are "sticking" with no surprises.
Congrats on PGNT. I know you were talking about it when it was at a buck. I bought some around $2.57. Stock remains ridiculously cheap. But they have been able to execute.
The SMDM CC sounded very positive. They have been having trouble keeping the carpool karaoke mic in stock. They were selling 2000 a day at one point, now selling hundreds a day. I'm not sure how long this trend will last but I think now through the next year looks bright.
Thanks for the input Gilead23.
Here is some more GLGI analysis
GLGI - Any reason to think GLGI won't continue these .06 quarters?
CVLB - Sales and marketing expense came in way higher than I expected. They are spending alot of money to generate sales.
Some notes from the call:
Very upbeat on the call almost too much for me. Mentioned they think "The sky is the limit", "land grab" in the telehealth market.
There were many callers on the call. Maybe 7? - showing alot of interest in the company.
Talked about multiple new product possibilites.
When asked about uplisting they said it is a near term priority and they would do is as soon as possible and when pressed on a timeline said "I would hope within the year"
Said they spent about $100K cash and some more in stock to purchase the Veritas MD platform that probably $1-$5Million put into it.
Veritas MD platform is finished they are just adding a few final features and working on scalability of the platform.
They said pdf-simpli could get to $10M run rate.
About spending money they said they would accept new capital only in ways that is accretive and makes sense. "We care about the equity". There are "no big salaries" on our team. Not looking to make a decision to take on capital so that they'll get a paycheck. Concerned about cost of capital, what is the return for shareholders as they are one of the biggest.
Guidance for next year: no formal guidance. They said "Assuming current trends continue tough not to be 75 -100Million revenue range next year."
They said "We know we have great unit economics"
LEAT - Great quarter, and it is the next quarter that is the largest quarter. I don't think there has been any slowdown, and I think at first the distributors weren't taking as much new product, whereas that has now changed. They also talked about ecommerce being a large contributor. So the next quarter will probably be significant. In their press release from the previous quarter they had previously downplayed results not expecting much from this quarter. They were very upbeat on the conference call. They seemed almost disappointed that there was only one question.
SCIA 10Q from 8/7
Net Income down to zero.
"Thus, we expect revenue to be lower in the second half of 2020 compared to the first six months of this year."
https://www.otcmarkets.com/filing/html?id=14318113&guid=OOR6UH20MGpAhZh
Press Release is out, they do sound optimistic on next quarter, and that they will get new contract wins and orders that they can put into their backlog.
https://www.otcmarkets.com/stock/OPXS/news/Optex-Systems-Holdings-Inc-Announces-Third-Quarter-of-Fiscal-Year-2020-Financial-Highlights?id=270487
OPXS 10q out
Looks like the warrants obscured the numbers again and made it look like a loss. EBITDA doubled, but it seems like it was all due to higher gold prices for redemptions on gold they use on the lenses. So seems flat in actuality.
https://www.otcmarkets.com/filing/html?id=14325576&guid=K1R6UKC9-DOqE3h